Imaging and management of calcium pyrophosphate deposition disease
- PMID: 39775910
- PMCID: PMC12234802
- DOI: 10.1007/s00256-024-04859-1
Imaging and management of calcium pyrophosphate deposition disease
Abstract
The radiological manifestations of calcium pyrophosphate deposition (CPPD) revolve around two main axes: the asymptomatic form and CPPD disease. The latter is a consequence of an immune response to calcium phosphate crystals. Chondrocalcinosis is broadly considered the radiographic manifestation of CPPD regardless of whether it is asymptomatic or associated with inflammatory arthritis. CPPD is associated with osteoarthritis although the direction of such association is still unclear. Apart from the detection of CPP crystals in synovial fluid, imaging (mainly conventional radiography and increasingly ultrasound) plays a central role in the diagnosis of CPPD disease. Recently, CT has been added as a diagnostic tool, especially in deep anatomic locations such as crowned dens. To date, no treatment is effective in dissolving CPP crystals. For now, the focus of current treatment strategies remains inflammation control. Our aim is to review the epidemiology, pathogenesis, and clinical and imaging manifestations of asymptomatic and symptomatic CPPD. We will also discuss recent consensus definitions and classifications of CPPD disease.
Keywords: CPPD; Calcium crystal; Calcium pyrophosphate; Osteoarthritis.
© 2025. The Author(s), under exclusive licence to International Skeletal Society (ISS).
Conflict of interest statement
Declarations. Conflict of interest: A.G. is shareholder of BICL, LLC and consultant to Novartis, TissueGene, Coval, Medipost, Formation Bio, Pacira, ICM, Levicept, 4Moving Biotech, Peptinov, and Scarcell Therapeutics. W.I., J.Y. and M.J and have no conflict of interest.
Similar articles
-
Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?-The time has come to reconsider the nomenclature of calcium pyrophosphate deposition.Ann Rheum Dis. 2025 Aug;84(8):1287-1292. doi: 10.1016/j.ard.2025.04.004. Epub 2025 May 1. Ann Rheum Dis. 2025. PMID: 40312208 Review.
-
Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis.Osteoarthritis Cartilage. 2016 Jun;24(6):973-81. doi: 10.1016/j.joca.2016.01.136. Epub 2016 Jan 27. Osteoarthritis Cartilage. 2016. PMID: 26826301
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Calcium pyrophosphate deposition disease.Lancet Rheumatol. 2024 Nov;6(11):e791-e804. doi: 10.1016/S2665-9913(24)00122-X. Epub 2024 Jul 29. Lancet Rheumatol. 2024. PMID: 39089298 Review.
-
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2. Cochrane Database Syst Rev. 2022. PMID: 35556242 Free PMC article.
References
-
- Kohn NN The Significance of Calcium Phosphate Crystals in the Synovial Fluid of Arthritic Patients: The ‘Pseudogout Syndrome’: II. Identification of Crystals. Ann. Intern. Med 56, 738 (1962). - PubMed
-
- Jarraya M, Roemer F, Kwoh CK & Guermazi A Crystal arthropathies and osteoarthritis—where is the link? Skeletal Radiol. 52, 2037–2043 (2023). - PubMed
-
- Felson DT et al. Risk factors for incident radiographic knee osteoarthritis in the elderly. The framingham study. Arthritis Rheum. 40, 728–733 (1997). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources